Judge Dyk Explains Takeda Loss In IP Fight Over Hemlibra

U.S. Circuit Judge Timothy B. Dyk has unsealed his opinion in a Delaware federal court case explaining why he found a Takeda Pharmaceutical Co. Ltd. unit's antibody patent was too broad...

Already a subscriber? Click here to view full article